Well Lead Medical Co LtdSSE: 603309

Announcement on Convening the Q3 2025 Performance Briefing

Oct 21, 2025 · Issued by Well Lead Medical Co Ltd via Shanghai Stock Exchange

Filed with SSE · Oct 21, 2025

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2025-performance-briefing-445

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Well Lead Medical Co Ltd on 6ix

Earlier from Well Lead Medical

Announcement on Implementation of Repurchase and Cancellation of Equity Incentive Restricted StocksOct 18, 2025
Announcement on Pledge and Release of Pledge of Partial Shares of ShareholderOct 14, 2025
Announcement on Obtaining Class II Medical Device Registration Certificate for the Wholly-owned Subsidiary's ProductSep 26, 2025
Announcement on Obtaining Class II Medical Device Registration Certificate for the Subsidiary's ProductSep 5, 2025
Announcement on Resignation of Non-independent Director and Election of Employee DirectorAug 19, 2025

Later from Well Lead Medical

Announcement on the Inclusion of the Company’s Products in the "Guangzhou Innovative Drug and Medical Device Product Catalog"Oct 30, 2025
Notice on Convening the 2nd Extraordinary General Meeting in 2025Nov 26, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Dec 12, 2025
Announcement on Completing Industrial and Commercial Change RegistrationDec 13, 2025
Announcement on Pledge of Partial Shares of Controlling ShareholderDec 19, 2025

All Well Lead Medical news releases

Follow Well Lead Medical into a list and get an email when it puts out news.

Follow Well Lead Medical